COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases

Sudden cardiac death is commonly seen due to arrhythmias, which is a common cardiac manifestation seen in COVID-19 patients, especially those with underlying cardiovascular disease (CVD). Administration of hydroxychloroquine (HCQ) as a potential treatment option during SARS-CoV-2, initially gained p...

Descripción completa

Detalles Bibliográficos
Autores principales: Raza, Hussain Ahmed, Tariq, Javeria, Agarwal, Vikas, Gupta, Latika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775739/
https://www.ncbi.nlm.nih.gov/pubmed/33386447
http://dx.doi.org/10.1007/s00296-020-04759-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775739/
https://www.ncbi.nlm.nih.gov/pubmed/33386447
http://dx.doi.org/10.1007/s00296-020-04759-2

Ejemplares similares